Volume 4, Issue 1 (Winter 2023)
J Vessel Circ 2023, 4(1): 37-44 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Heydari H, Rezvan S, Feizollahjani M, Movahedi Z. COVID-19 and Kawasaki Disease in a 4-year-old Child: A Case Report. J Vessel Circ 2023; 4 (1) :37-44
URL: http://jvessels.muq.ac.ir/article-1-253-en.html
URL: http://jvessels.muq.ac.ir/article-1-253-en.html
1- Department of Pediatrics, School of Medicine, Hazrat-e Fateme Masoume Hospital, Qom University of Medical Sciences, Qom, Iran.
2- Department of Radiology, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
2- Department of Radiology, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
Abstract: (500 Views)
Background and Aim: Although Kawasaki disease syndromes have previously been linked to other viral infections, patients with higher levels of pro-inflammatory markers than different cohorts reflect a particularly strong immunological reaction to SARS-CoV-2. This article examines a comorbidity between Kawasaki and COVID-19 in a 4-year-old child who complained of fever.
Case Report: We describe the case of a 4-year-old child admitted and diagnosed with classic Kawasaki disease, who also screened positive for COVID-19 in the setting of fever and minimal respiratory symptoms. The patient has been treated per treatment guidelines with intravenous immunoglobulin and high-dose aspirin and subsequently effervesced with a resolution of her clinical symptoms, with instruction to quarantine at home for 14 days from the date of her positive test results for COVID-19.
Conclusion: Considering that the results of this case report are essential for other pediatric care professionals with COVID-19, the understanding of clinical demonstration patterns continues to evolve. More information on the clinical course of children with COVID-19, especially in cases where the disease coincides with the Kawasaki disease, is necessary.
Case Report: We describe the case of a 4-year-old child admitted and diagnosed with classic Kawasaki disease, who also screened positive for COVID-19 in the setting of fever and minimal respiratory symptoms. The patient has been treated per treatment guidelines with intravenous immunoglobulin and high-dose aspirin and subsequently effervesced with a resolution of her clinical symptoms, with instruction to quarantine at home for 14 days from the date of her positive test results for COVID-19.
Conclusion: Considering that the results of this case report are essential for other pediatric care professionals with COVID-19, the understanding of clinical demonstration patterns continues to evolve. More information on the clinical course of children with COVID-19, especially in cases where the disease coincides with the Kawasaki disease, is necessary.
Type of Study: case report |
Subject:
cardiovascular diseases
Received: 2023/04/4 | Accepted: 2023/05/1 | Published: 2022/11/1
Received: 2023/04/4 | Accepted: 2023/05/1 | Published: 2022/11/1
References
1. Noori E, Vahedian M, Rezvan S, Minaei N, Tabaraii R. The proposed scoring system for hospitalization or discharge of patients with COVID-19. J Emerg PractTrauma. 2022; 8(1):60-3. [DOI:10.34172/jept.2021.08] [DOI:10.34172/jept.2021.08]
2. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-42. [DOI:10.1001/jama.2020.2648] [PMID] [DOI:10.1001/jama.2020.2648]
3. Moghadam VD, Momenimovahed Z, Ghorbani M, Khodadadi J. Linezolid a potential treatment for COVID-19 coinfections. Braz J Anesthesiol. 2021; 71(2):198. [DOI:10.1016/j.bjane.2020.12.019] [PMID] [DOI:10.1016/j.bjane.2020.12.019]
4. Eastin C, Eastin T. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. J Emerg Med. 2020; 58(4):712-3. [DOI:10.1016/j.jemermed.2020.04.006] [DOI:10.1016/j.jemermed.2020.04.006]
5. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18):1708-20.[DOI:10.1056/NEJMoa2002032] [PMID] [DOI:10.1056/NEJMoa2002032]
6. Rezvan S, Nasiri B, Farahmand H, Ahmadi J, Noori E, Bazmandegan G, et al. Frequency of ABO Blood Groups in Patients With COVID-19 Referred to Ali Ibn Abi Taleb Hospital in Rafsanjan in 2020. J Vessel Circ. 2021; 2(4):171-8. [DOI:10.32598/JVC.2.4.64.7] [DOI:10.32598/JVC.2.4.64.7]
7. Harnden A, Takahashi M, Burgner D. Kawasaki disease. BMJ. 2009; 338:b1514. [DOI:10.1136/bmj.b1514] [PMID] [DOI:10.1136/bmj.b1514]
8. Razavi SMR, Azadegan M, Rezvan S, Noori E. A case report of Kawasaki Disease with manifestations of acute renal. J Vessel Circ. 2020; 1(2):17-20. [DOI:10.29252/jvesselcirc.1.2.17] [DOI:10.29252/jvesselcirc.1.2.17]
9. Melish ME, Hicks RM, Larson EJ. Mucocutaneous lymph node syndrome in the United States. Am J Dis Child. 1976; 130(6):599-607. [DOI:10.1001/archpedi.1976.02120070025006] [PMID] [DOI:10.1001/archpedi.1976.02120070025006]
10. Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, et al. COVID-19 and Kawasaki disease: Novel virus and novel case. Hosp Pediatr. 2020; 10(6):537-40. [DOI:10.1542/hpeds.2020-0123] [PMID] [DOI:10.1542/hpeds.2020-0123]
11. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004; 110(17):2747-71. [DOI:10.1161/01.CIR.0000145143.19711.78] [PMID] [DOI:10.1161/01.CIR.0000145143.19711.78]
12. Rowley AH, Shulman ST. The epidemiology and pathogenesis of Kawasaki disease. Front Pediatr. 2018; 6:374.[DOI:10.3389/fped.2018.00374] [PMID] [DOI:10.3389/fped.2018.00374]
13. Wang L, Zhang S, Ma J, Ni J, Wang J, Li X, et al. Kawasaki disease-management strategies given symptoms overlap to COVID-19: A review. JNMA J Nepal Med Assoc. 2021; 59(236):417-24. [DOI:10.31729/jnma.5698] [PMID] [DOI:10.31729/jnma.5698]
14. Kim JH, Yu JJ, Lee J, Kim MN, Ko HK, Choi HS, et al. Detection rate and clinical impact of respiratory viruses in children with Kawasaki disease. Korean J Pediatr. 2012; 55(12):470-3.[DOI:10.3345/kjp.2012.55.12.470] [PMID] [DOI:10.3345/kjp.2012.55.12.470]
15. Jordan-Villegas A, Chang ML, Ramilo O, Mejías A. Concomitant respiratory viral infections in children with Kawasaki disease. Pediatr Infect Dis J. 2010; 29(8):770-2. [DOI:10.1097/INF.0b013e3181dba70b] [PMID] [DOI:10.1097/INF.0b013e3181dba70b]
16. Rauf A, Vijayan A, John ST, Krishnan R, Latheef A. Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic. Indian J Pediatr. 2020; 87(9):745-7. [DOI:10.1007/s12098-020-03357-1] [PMID] [DOI:10.1007/s12098-020-03357-1]
17. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395(10237):1607-8.[DOI:10.1016/S0140-6736(20)31094-1] [PMID] [DOI:10.1016/S0140-6736(20)31094-1]
18. Schroeder AR, Wilson KM, Ralston SL. COVID-19 and Kawasaki disease: Finding the signal in the noise. Hosp Pediatr. 2020; 10(10):e1-3. [DOI:10.1542/hpeds.2020-000356] [PMID] [DOI:10.1542/hpeds.2020-000356]
19. Ziaee V, Assari R, Mamishi S, Zeinaloo A, Mohammadpour M, Malekzadeh I, et al. An algorithmic approach to multisystem inflammatory syndrome in children with COVID-19: Tehran children's medical center protocol. Iran J Pediatr. 2020; 30(5):e108617. [DOI:10.5812/ijp.108617] [DOI:10.5812/ijp.108617]
20. Anderson MS, Todd JK, Glodé MP. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics. 2005; 115(4):e428-33. [DOI:10.1542/peds.2004-1824] [PMID] [DOI:10.1542/peds.2004-1824]
21. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020; 145(6):e20200702. [DOI:10.1542/peds.2020-0702] [PMID] [DOI:10.1542/peds.2020-0702]
22. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; 382(10):929-36. [DOI:10.1056/NEJMoa2001191] [PMID] [DOI:10.1056/NEJMoa2001191]
23. Dugas M, Stéfan T, Lépine J, Blouin P, Poirier AA, Carnovale V, et al. COVID-19 in children with brain-based developmental disabilities: A rapid review update. medRxiv. 2021. [DOI:10.1101/2021.03.17.21253283] [DOI:10.1101/2021.03.17.21253283]
24. Parri N, Lenge M, Buonsenso D; Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in Pediatric Emergency Departments in Italy. N Engl J Med. 2020; 383(2):187-90. [DOI:10.1056/NEJMc2007617] [PMID] [DOI:10.1056/NEJMc2007617]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Owned by Qom University of Medical Sciences
Published by Qom University of Medical Sciences Press
eISSN: 2717-0357
Email: jvessels[at]muq.ac.ir
j.vessels.circul[at]gmail.com
